Motilal Oswal BSE Healthcare ETF-Growth
Equity
Sectoral-Pharma
₹0.24% 1D
NAV on
Overview
Chart
Returns
Asset Allocation
Fund Info
Risk & Return Ratio
Fund Overview
- Rating
Not Rated - Minimum Investment₹500
- NAV (Net Asset Value)₹N/A
- AUM (Fund size)₹42 Cr
- Created on5 July 2022
Fund Ranking
#3
/ 15 in Sectoral-Pharma
Risk Level
Very High
Very High
Loading...
Returns
Trailing Return
Rolling Return
- 6 Month22.3%
- 1 Year12.6%
- 3 Year (CAGR)24.0%
- All Time (CAGR)22.0%
Category Return
- 6 Month21.5%
- 1 Year13.1%
- 3 Year (CAGR)22.0%
- All Time (CAGR)-
Asset Allocation
- Equity99.8%
- Other0.2%
Top 5 Holdings
Top 5 Sectors
- Aarti Drugs0.09%
- Anuh Pharma0.01%
- Apollo Hospitals Enterprise5.67%
- Astrazeneca Pharma India0.37%
- Aurobindo Pharma2.71%
Fund Information
- Expense Ratio0.43%
- Exit LoadNo Exit Load
- Lock-In PeriodNo Lock-In
Risk & Return Ratio
- Sharpe Ratio
Sharpe Ratio evaluates a fund's return relative to its risk. Higher values signify better risk-adjusted performance. 1.06 - Standard Deviation
Standard deviation measures the volatility of a fund's returns. The higher the value, the riskier the investment. 16.62 - Alpha
Alpha in mutual funds measures excess return relative to a benchmark, indicating a manager's skill at generating returns beyond market performance. -0.25 - Beta
Beta in mutual funds indicates a fund's sensitivity to market changes. A beta over 1 means it's more volatile than the market, while below 1 implies less volatility. 1.00